NOVEL PEPTIDE BINDER TO GLYPICAN-3 FOR TARGETED RADIOPHARMACEUTICAL THERAPY OF HEPATOCELLULAR CARCINOMA

被引：0
|
作者：
Song, Ken [1 ]
机构：
[1] RayzeBio, San Diego, CA USA
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Novel peptide binder to Glypican-3 for targeted radiopharmaceutical therapy of hepatocellular carcinoma
    Li, Gary
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Salvador, Katrina
    Richardson, Samantha
    Guest, Matt
    Noncovich, Alain
    Bhat, Abhijit
    Han, Guangzhou
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] NOVEL GLYPICAN-3 TARGETED PEPTIDE BINDER FOR THE DEVELOPMENT OF RADIOPHARMACEUTICAL THERAPY TO TREAT HEPATOCELLULAR CARCINOMA
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Noncovich, Alain
    Horton, Steven
    Salvador, Katrina
    Richardson, Samantha
    Guest, Matt
    Chen, Greg
    Bhat, Abhijit
    Han, Guangzhou
    Li, Gary
    HEPATOLOGY, 2023, 78 : S1922 - S1923
  • [3] Preclinical Characterization of a Novel Peptide Binder to Glypican-3 for Targeted Radiopharmaceutical Therapy of Hepatocellular Carcinoma
    Li, G.
    Lin, F.
    Clift, R.
    Ehara, T.
    Yanagida, H.
    Horton, S.
    Salvador, K.
    Richardson, S.
    Guest, M.
    Noncovich, A.
    Bhat, A.
    Han, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S62 - S62
  • [4] Peptide Binder to Glypican-3 as a Theranostic Agent for Hepatocellular Carcinoma
    Lin, Fanching
    Clift, Renee
    Ehara, Takeru
    Yanagida, Hayato
    Horton, Steven
    Noncovich, Alain
    Guest, Matt
    Kim, Daniel
    Salvador, Katrina
    Richardson, Samantha
    Miller, Terra
    Han, Guangzhou
    Bhat, Abhijit
    Song, Kenneth
    Li, Gary
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (04) : 586 - 592
  • [5] A Novel Peptide Binder to Glypican-3 Demonstrates High Specificity as a Theranostic Agent for Hepatocellular Carcinoma
    Bal, Chandraskhar
    Ballal, Sanjana
    Kallur, Kumarswamy
    Yuan, Ye
    Rearden, Jessica
    Shah, Kathryn
    Lorenz, Charlotte
    Moran, Susan
    Song, Ken
    Sen, Ishita
    Thakral, Parul
    Malik, Dharmender
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [6] Sorafenib encapsulated in nanocarrier functionalized with glypican-3 specific peptide for targeted therapy of hepatocellular carcinoma
    Feng, Shuo
    Zhou, Juan
    Li, Zhao
    Appelman, Henry D.
    Zhao, Lili
    Zhu, Jiye
    Wang, Thomas D.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 184
  • [7] Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy
    Couzinet, Arnaud
    Suzuki, Toshihiro
    Nakatsura, Tetsuya
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (10) : 895 - 909
  • [8] Glypican-3: A novel diagnostic marker for hepatocellular carcinoma.
    Sherman, M
    Filmus, J
    Wanless, I
    Capurro, M
    HEPATOLOGY, 2002, 36 (04) : 692A - 692A
  • [9] Glypican-3 A Novel Diagnostic Marker for Hepatocellular Carcinoma and More
    Kandil, Dina H.
    Cooper, Kumarasen
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (02) : 125 - 129
  • [10] Glypican-3 Targeted Human Heavy Chain Antibody as a Drug Carrier for Hepatocellular Carcinoma Therapy
    Hanaoka, Hirofumi
    Nagaya, Tadanobu
    Sato, Kazuhide
    Nakamura, Yuko
    Watanabe, Rira
    Harada, Toshiko
    Gao, Wei
    Feng, Mingqian
    Phung, Yen
    Kim, Insook
    Paik, Chang H.
    Choyke, Peter L.
    Ho, Mitchell
    Kobayashi, Hisataka
    MOLECULAR PHARMACEUTICS, 2015, 12 (06) : 2151 - 2157
12345